Cargando…
Four-year follow-up outcomes after stereotactic body radiation therapy for central early-stage non-small cell lung cancer
BACKGROUND: Previous research has shown that stereotactic body radiation therapy (SBRT) can achieve a high level of tumor control in patients with early-stage non-small cell lung cancer (NSCLC). However, to date, such studies have mainly focused on peripheral early-stage patients. This study aimed t...
Autores principales: | Sun, Xiaojiang, Li, Yefei, Zhu, Yaoyao, Li, Qian, Yuan, Xiaoshuai, Lin, Qingren, Weng, Denghu, Xu, Qinghua, Liu, Hui, Xu, Yaping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481586/ https://www.ncbi.nlm.nih.gov/pubmed/32953519 http://dx.doi.org/10.21037/tlcr-20-851 |
Ejemplares similares
-
The CT appearance pattern of radiation-induced lung injury and tumor recurrence after stereotactic body radiation therapy in early stage non-small cell lung cancer
por: Li, Qian, et al.
Publicado: (2020) -
Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease
por: Liu, Yuanjun, et al.
Publicado: (2020) -
Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis
por: Lin, Qingren, et al.
Publicado: (2019) -
Analysis of Clinical and Dosimetric Factors Influencing Radiation-Induced Lung Injury in Patients with Lung Cancer
por: Han, Shuiyun, et al.
Publicado: (2015) -
Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study
por: Hu, Min, et al.
Publicado: (2020)